nodes	percent_of_prediction	percent_of_DWPC	metapath
Lopinavir—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.697	1	CiPCiCtD
Lopinavir—CYP1A2—Clobetasol propionate—psoriasis	0.0341	0.117	CbGbCtD
Lopinavir—CYP2B6—Cholecalciferol—psoriasis	0.0202	0.0692	CbGbCtD
Lopinavir—CYP1A2—Methoxsalen—psoriasis	0.0179	0.0613	CbGbCtD
Lopinavir—CYP2D6—Hydroxyurea—psoriasis	0.0161	0.0552	CbGbCtD
Lopinavir—CYP2C19—Cholecalciferol—psoriasis	0.0128	0.044	CbGbCtD
Lopinavir—CYP3A4—Calcitriol—psoriasis	0.0121	0.0413	CbGbCtD
Lopinavir—CYP2C9—Cholecalciferol—psoriasis	0.0107	0.0366	CbGbCtD
Lopinavir—CYP2D6—Cholecalciferol—psoriasis	0.00976	0.0334	CbGbCtD
Lopinavir—CYP3A4—Methoxsalen—psoriasis	0.00937	0.0321	CbGbCtD
Lopinavir—ABCB1—Mycophenolate mofetil—psoriasis	0.00899	0.0308	CbGbCtD
Lopinavir—CYP2C19—Prednisone—psoriasis	0.0089	0.0305	CbGbCtD
Lopinavir—CYP2B6—Dexamethasone—psoriasis	0.00875	0.0299	CbGbCtD
Lopinavir—CYP2C19—Cyclosporine—psoriasis	0.00844	0.0289	CbGbCtD
Lopinavir—ABCB1—Betamethasone—psoriasis	0.00771	0.0264	CbGbCtD
Lopinavir—ABCB1—Prednisolone—psoriasis	0.00761	0.026	CbGbCtD
Lopinavir—ABCB1—Hydrocortisone—psoriasis	0.00721	0.0247	CbGbCtD
Lopinavir—ABCB1—Prednisone—psoriasis	0.00718	0.0246	CbGbCtD
Lopinavir—CYP2C9—Cyclosporine—psoriasis	0.00702	0.024	CbGbCtD
Lopinavir—ABCB1—Cyclosporine—psoriasis	0.00681	0.0233	CbGbCtD
Lopinavir—CYP2D6—Cyclosporine—psoriasis	0.00642	0.022	CbGbCtD
Lopinavir—CYP3A4—Cholecalciferol—psoriasis	0.00621	0.0213	CbGbCtD
Lopinavir—CYP2C19—Dexamethasone—psoriasis	0.00556	0.019	CbGbCtD
Lopinavir—CYP3A4—Mycophenolate mofetil—psoriasis	0.00538	0.0184	CbGbCtD
Lopinavir—CYP3A4—Triamcinolone—psoriasis	0.00538	0.0184	CbGbCtD
Lopinavir—CYP2C9—Dexamethasone—psoriasis	0.00462	0.0158	CbGbCtD
Lopinavir—CYP3A4—Betamethasone—psoriasis	0.00462	0.0158	CbGbCtD
Lopinavir—CYP3A4—Prednisolone—psoriasis	0.00456	0.0156	CbGbCtD
Lopinavir—ABCB1—Dexamethasone—psoriasis	0.00448	0.0154	CbGbCtD
Lopinavir—CYP3A4—Hydrocortisone—psoriasis	0.00432	0.0148	CbGbCtD
Lopinavir—CYP3A4—Prednisone—psoriasis	0.0043	0.0147	CbGbCtD
Lopinavir—CYP2D6—Dexamethasone—psoriasis	0.00423	0.0145	CbGbCtD
Lopinavir—CYP3A4—Cyclosporine—psoriasis	0.00408	0.014	CbGbCtD
Lopinavir—ABCB1—Methotrexate—psoriasis	0.0036	0.0123	CbGbCtD
Lopinavir—CYP3A4—Dexamethasone—psoriasis	0.00269	0.0092	CbGbCtD
Lopinavir—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.000812	0.0724	CbGpPWpGaD
Lopinavir—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000614	0.0547	CbGpPWpGaD
Lopinavir—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000565	0.0503	CbGpPWpGaD
Lopinavir—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00056	0.0499	CbGpPWpGaD
Lopinavir—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000527	0.047	CbGpPWpGaD
Lopinavir—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000503	0.0449	CbGpPWpGaD
Lopinavir—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00038	0.0339	CbGpPWpGaD
Lopinavir—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.00035	0.0312	CbGpPWpGaD
Lopinavir—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000347	0.0309	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL22—psoriasis	0.000298	0.0266	CbGpPWpGaD
Lopinavir—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000296	0.0264	CbGpPWpGaD
Lopinavir—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000229	0.0204	CbGpPWpGaD
Lopinavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000209	0.0186	CbGpPWpGaD
Lopinavir—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000206	0.0184	CbGpPWpGaD
Lopinavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000169	0.0151	CbGpPWpGaD
Lopinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000158	0.0141	CbGpPWpGaD
Lopinavir—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000156	0.0139	CbGpPWpGaD
Lopinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000145	0.013	CbGpPWpGaD
Lopinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000144	0.0128	CbGpPWpGaD
Lopinavir—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000143	0.0128	CbGpPWpGaD
Lopinavir—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000142	0.0127	CbGpPWpGaD
Lopinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000128	0.0114	CbGpPWpGaD
Lopinavir—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000123	0.011	CbGpPWpGaD
Lopinavir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000123	0.011	CbGpPWpGaD
Lopinavir—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000121	0.0108	CbGpPWpGaD
Lopinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000118	0.0105	CbGpPWpGaD
Lopinavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000117	0.0104	CbGpPWpGaD
Lopinavir—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.98e-05	0.0089	CbGpPWpGaD
Lopinavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.6e-05	0.00856	CbGpPWpGaD
Lopinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	9.5e-05	0.00847	CbGpPWpGaD
Lopinavir—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.38e-05	0.00836	CbGpPWpGaD
Lopinavir—CYP2B6—Biological oxidations—CYP2S1—psoriasis	9e-05	0.00803	CbGpPWpGaD
Lopinavir—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	8.88e-05	0.00792	CbGpPWpGaD
Lopinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	7.7e-05	0.00687	CbGpPWpGaD
Lopinavir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	7.6e-05	0.00677	CbGpPWpGaD
Lopinavir—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	7.31e-05	0.00652	CbGpPWpGaD
Lopinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.08e-05	0.00632	CbGpPWpGaD
Lopinavir—CYP2C19—Biological oxidations—CYP2S1—psoriasis	6.8e-05	0.00607	CbGpPWpGaD
Lopinavir—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	6.71e-05	0.00598	CbGpPWpGaD
Lopinavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.69e-05	0.00597	CbGpPWpGaD
Lopinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.62e-05	0.0059	CbGpPWpGaD
Lopinavir—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	6.6e-05	0.00588	CbGpPWpGaD
Lopinavir—CYP2D6—Biological oxidations—CYP2S1—psoriasis	6.26e-05	0.00558	CbGpPWpGaD
Lopinavir—CYP2C9—Biological oxidations—CYP2S1—psoriasis	6.2e-05	0.00553	CbGpPWpGaD
Lopinavir—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	6.17e-05	0.0055	CbGpPWpGaD
Lopinavir—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	6.12e-05	0.00546	CbGpPWpGaD
Lopinavir—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	6.07e-05	0.00541	CbGpPWpGaD
Lopinavir—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	6.03e-05	0.00538	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	5.91e-05	0.00527	CbGpPWpGaD
Lopinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.65e-05	0.00504	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-C—psoriasis	5.65e-05	0.00503	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL13—psoriasis	5.61e-05	0.005	CbGpPWpGaD
Lopinavir—CYP1A2—Biological oxidations—CYP2S1—psoriasis	5.3e-05	0.00473	CbGpPWpGaD
Lopinavir—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	5.23e-05	0.00466	CbGpPWpGaD
Lopinavir—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	5.22e-05	0.00465	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL17A—psoriasis	5.16e-05	0.0046	CbGpPWpGaD
Lopinavir—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	5.14e-05	0.00458	CbGpPWpGaD
Lopinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.94e-05	0.0044	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL12B—psoriasis	4.8e-05	0.00428	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-E—psoriasis	4.69e-05	0.00418	CbGpPWpGaD
Lopinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.61e-05	0.00411	CbGpPWpGaD
Lopinavir—CYP1A2—Tryptophan metabolism—CAT—psoriasis	4.57e-05	0.00408	CbGpPWpGaD
Lopinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.36e-05	0.00389	CbGpPWpGaD
Lopinavir—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.09e-05	0.00365	CbGpPWpGaD
Lopinavir—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.03e-05	0.0036	CbGpPWpGaD
Lopinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.94e-05	0.00351	CbGpPWpGaD
Lopinavir—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	3.92e-05	0.0035	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	3.88e-05	0.00346	CbGpPWpGaD
Lopinavir—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	3.61e-05	0.00322	CbGpPWpGaD
Lopinavir—CYP3A4—Tryptophan metabolism—CAT—psoriasis	3.53e-05	0.00315	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL10—psoriasis	3.51e-05	0.00313	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IL4—psoriasis	3.41e-05	0.00304	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-B—psoriasis	3.34e-05	0.00298	CbGpPWpGaD
Lopinavir—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	3.33e-05	0.00297	CbGpPWpGaD
Lopinavir—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.11e-05	0.00277	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.09e-05	0.00276	CbGpPWpGaD
Lopinavir—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	3.06e-05	0.00273	CbGpPWpGaD
Lopinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.04e-05	0.00271	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.83e-05	0.00252	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.54e-05	0.00226	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.2e-05	0.00196	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.11e-05	0.00188	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—IFNG—psoriasis	2.06e-05	0.00184	CbGpPWpGaD
Lopinavir—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.06e-05	0.00184	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.92e-05	0.00171	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.92e-05	0.00171	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—NDUFA5—psoriasis	1.81e-05	0.00161	CbGpPWpGaD
Lopinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.8e-05	0.0016	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.64e-05	0.00147	CbGpPWpGaD
Lopinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.64e-05	0.00147	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.58e-05	0.00141	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.56e-05	0.00139	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—CYP2S1—psoriasis	1.54e-05	0.00137	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—NDUFA5—psoriasis	1.37e-05	0.00122	CbGpPWpGaD
Lopinavir—ABCB1—Allograft Rejection—TNF—psoriasis	1.34e-05	0.00119	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—NDUFA5—psoriasis	1.34e-05	0.00119	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.33e-05	0.00118	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.28e-05	0.00114	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—NDUFA5—psoriasis	1.26e-05	0.00112	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—NDUFA5—psoriasis	1.25e-05	0.00111	CbGpPWpGaD
Lopinavir—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.24e-05	0.00111	CbGpPWpGaD
Lopinavir—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.18e-05	0.00106	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—CYP2S1—psoriasis	1.16e-05	0.00104	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.16e-05	0.00104	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—CYP2S1—psoriasis	1.14e-05	0.00101	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—CYP2S1—psoriasis	1.07e-05	0.000954	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—NDUFA5—psoriasis	1.07e-05	0.000951	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—CYP2S1—psoriasis	1.06e-05	0.000946	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.94e-06	0.000886	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—CYP2S1—psoriasis	9.07e-06	0.000808	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	8.8e-06	0.000785	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.48e-06	0.000756	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—NDUFA5—psoriasis	8.23e-06	0.000734	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.69e-06	0.000686	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—CARM1—psoriasis	7.52e-06	0.00067	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—CYP2S1—psoriasis	7e-06	0.000624	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.59e-06	0.000588	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.1e-06	0.000544	CbGpPWpGaD
Lopinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.81e-06	0.000518	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—CARM1—psoriasis	5.68e-06	0.000507	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.56e-06	0.000496	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—CARM1—psoriasis	5.55e-06	0.000494	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.31e-06	0.000474	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—CARM1—psoriasis	5.23e-06	0.000466	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—CARM1—psoriasis	5.18e-06	0.000462	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.84e-06	0.000432	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.75e-06	0.000424	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—CAT—psoriasis	4.62e-06	0.000412	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—CARM1—psoriasis	4.43e-06	0.000395	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.14e-06	0.000369	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—APOE—psoriasis	3.59e-06	0.00032	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—CAT—psoriasis	3.49e-06	0.000312	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—CARM1—psoriasis	3.42e-06	0.000305	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—CAT—psoriasis	3.41e-06	0.000304	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—CAT—psoriasis	3.21e-06	0.000287	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—CAT—psoriasis	3.19e-06	0.000284	CbGpPWpGaD
Lopinavir—CYP2B6—Metabolism—PPARG—psoriasis	3.13e-06	0.000279	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—CAT—psoriasis	2.72e-06	0.000243	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—APOE—psoriasis	2.72e-06	0.000242	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—APOE—psoriasis	2.65e-06	0.000236	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—APOE—psoriasis	2.5e-06	0.000223	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—APOE—psoriasis	2.48e-06	0.000221	CbGpPWpGaD
Lopinavir—CYP2C19—Metabolism—PPARG—psoriasis	2.37e-06	0.000211	CbGpPWpGaD
Lopinavir—ABCB1—Metabolism—PPARG—psoriasis	2.31e-06	0.000206	CbGpPWpGaD
Lopinavir—CYP2D6—Metabolism—PPARG—psoriasis	2.18e-06	0.000194	CbGpPWpGaD
Lopinavir—CYP2C9—Metabolism—PPARG—psoriasis	2.16e-06	0.000192	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—APOE—psoriasis	2.12e-06	0.000189	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—CAT—psoriasis	2.1e-06	0.000187	CbGpPWpGaD
Lopinavir—CYP1A2—Metabolism—PPARG—psoriasis	1.84e-06	0.000164	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—APOE—psoriasis	1.63e-06	0.000146	CbGpPWpGaD
Lopinavir—CYP3A4—Metabolism—PPARG—psoriasis	1.42e-06	0.000127	CbGpPWpGaD
